Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

MapLight Therapeutics, Inc. MPLT

Set alert

Price alert · MPLT

All alert types
6.96 USD +0.18 +2.65%

As of Nov 3, 12:13 PM ET

Bid
6.89 × 2
Ask
6.96 × 2
6.82 Day range 7.15
6.77 52-week range 40.43
YTD
-60.39%
1 year
-58.84%
Open
6.82
Prev close
6.78
Mkt cap
384.86M
Vol
93.27K
Avg vol
497.36K
EPS
-6.25
P/E
0.00
Div yield
0.00%
More statistics
Low
6.82
High
7.15
Forward P/E
-10.51
Beta
0.00
Short ratio
5.58
Inst. own
56.01%
Dividend
0.00
Ex-div date
Earnings
Sep 18, 2026
50-d avg
30.61
200-d avg
22.20
1y target
41.50

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for MPLT has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

5.70 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -4.8×
FY 2022: -25.5×FY 2023: -13.7×FY 2024: -9.8×FY 2025: -4.8×
FY 2022 5y median -11.7× FY 2025
P/S 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 1.7×
FY 2022: 36.4×FY 2023: 10.7×FY 2024: 6.6×FY 2025: 1.7×
FY 2022 5y median 8.6× FY 2025
P/FCF -5.6×
FY 2022: -27.8×FY 2023: -14.5×FY 2024: -9.5×FY 2025: -5.6×
FY 2022 5y median -12.0× FY 2025
EV/EBITDA -4.6×
FY 2022: -25.1×FY 2023: -12.4×FY 2024: -9.5×FY 2025: -4.6×
FY 2022 5y median -11.0× FY 2025
EV/Sales 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -17.9%
FY 2022: -3.6%FY 2023: -6.9%FY 2024: -10.5%FY 2025: -17.9%
FY 2022 5y median -8.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -35.2%
FY 2022: -143.8%FY 2023: -78.2%FY 2024: -67.3%FY 2025: -35.2%
FY 2022 5y median -72.7% FY 2025
ROIC -36.4%
FY 2022: -115.1%FY 2023: -74.2%FY 2024: -68.1%FY 2025: -36.4%
FY 2022 5y median -71.2% FY 2025
ROA -33.6%
FY 2022: -76.2%FY 2023: -60.9%FY 2024: -56.7%FY 2025: -33.6%
FY 2022 5y median -58.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 FY 2025
Operating Income -103.8%
FY 2022: 0.0%FY 2023: -83.3%FY 2024: -44.8%FY 2025: -103.8%
FY 2022 FY 2025
EPS (diluted) -95.7%
FY 2022: 0.0%FY 2023: -86.1%FY 2024: -39.6%FY 2025: -95.7%
FY 2022 FY 2025
Free Cash Flow -74.2%
FY 2022: 0.0%FY 2023: -92.0%FY 2024: -51.7%FY 2025: -74.2%
FY 2022 FY 2025

Financial Health

Current Ratio 20.0×
FY 2022: 2.5×FY 2023: 5.7×FY 2024: 7.2×FY 2025: 20.0×
FY 2022 5y median 6.4× FY 2025
Quick Ratio 20.0×
FY 2022: 2.5×FY 2023: 5.7×FY 2024: 7.2×FY 2025: 20.0×
FY 2022 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2022 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2022: 0.7×FY 2023: 1.3×FY 2024: 0.4×FY 2025: 0.3×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31